Back to today’s briefing

Story perspectives

Alltrna Champions Rare Disease Treatment on Rare Disease Day

3/1/2025

31 2

Summary

Story summary

On Rare Disease Day, Alltrna is on a mission to transform the landscape of rare genetic disease treatment with innovative tRNA therapies aimed at common mutations. With only 5% of genetic diseases having FDA-approved therapies, families like Lucas Oon's and Eddy Craig's face daily struggles with conditions like Angelman and Char syndromes, underscoring the critical need for awareness and support.

1 of 1

Story summary

On Rare Disease Day, Alltrna is on a mission to transform the landscape of rare genetic disease treatment with innovative tRNA therapies aimed at common mutations. With only 5% of genetic diseases having FDA-approved therapies, families like Lucas Oon's and Eddy Craig's face daily struggles with conditions like Angelman and Char syndromes, underscoring the critical need for awareness and support.